The combined chemotherapy of ifosfamide plus vindesine and cisplatin in advanced non-small cell lung cancer / 重庆医科大学学报
Journal of Chongqing Medical University
;
(12)1986.
Artículo
en Chino
| WPRIM
| ID: wpr-571214
ABSTRACT
0.05).The median duration of survival was eight months.The major toxicity was the inhibition of bone marrow,especially of leukocyte and platelet.Leukopenia and thrombocytopenia often appeared at day 8~12.ConlusionThe combined chemotherapy of ifosfamide plus vindesine and cisplatin is effective in advanced non-small cell lung cancer including the returm cases,and the toxicity is tolerable.If G-CSF is used as a complementary therapy,this regimen could be quite clinically valuable.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Chongqing Medical University
Año:
1986
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS